Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.
1 other identifier
interventional
15
1 country
1
Brief Summary
Increasing number of breast cancer patients are being treated with conservative surgery; without the need for mastectomy. The cosmetic sequel of breast conservative surgery can be unsatisfactory to the patient and may necessitate secondary surgery. The present study aims at improving the cosmetic outcome of breast conservative surgery. The defect remaining in the breast tissue after excision of the tumour will be filled with the underlying pectoralis major muscle. This pilot study will test the safety and efficacy of using the pectoralis major muscle for reconstructing a partial mastectomy defect. fifteen patients with early breast cancer scheduled for breast conservation will be recruited to this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 breast-cancer
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2019
CompletedFirst Submitted
Initial submission to the registry
September 13, 2019
CompletedFirst Posted
Study publicly available on registry
September 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedNovember 19, 2020
November 1, 2020
1.4 years
September 13, 2019
November 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The rate of major complications
The rate of major complications related to surgery that necessitate further intervention.
Six weeks after surgery.
The score of early cosmetic outcome
This is a categorical variable. The cosmetic score is reported according to the Harris method. In this method the overall cosmetic result is ranked as one of four scores. The maximum score is "Excellent" where the treated breast is identical to the other breast. Slight difference is scored as "Good". Marked difference without distortion is scored as " Fair". The least score is " Poor" where there is breast distortion.
Six weeks after surgery.
Secondary Outcomes (1)
The score of late cosmetic outcome
12 Months after surgery.
Other Outcomes (1)
The percentage of adequate resection
Two weeks after surgery.
Study Arms (1)
Post-tumourectomy reconstruction with myo-glandular flap.
EXPERIMENTALStandard tumourectomy followed by reconstruction with myo-glandular flap.
Interventions
Tumorectomy with surgical margin will be evaluated with frozen-section examination. Reconstruction starts with mobilization of skin flaps. The sternal head of the pectoralis major muscle will be disconnected from its insertion at the humerus. The muscle fibers will be mobilized off the chest wall. The pectoralis major receives dual blood supply. The pectoral branches of the thoraco-acromial artery enter the superior part of the muscle and the perforator branches of the internal mammary artery enter the medial part of the muscle. According to the location of the defect in the breast, the muscle will be mobilized based on one vascular pedicle. The muscle flap may consist of all or some segmental fibres of the sternal head of the pectoralis major muscle. In all cases, the muscle flap connection to the overlying breast parenchyma is kept intact and the clavicular head of the pectoralis major muscle is undisturbed. Closure of the cavity in layers over suction drain will follow.
Eligibility Criteria
You may qualify if:
- Patients with early breast cancer or phylloides tumor.
- Eligible for breast conservative surgery.
- Expected post-lumpectomy volume loss of 20-40% of breast volume.
- Tumor location in upper quadrants.
- Informed consent.
You may not qualify if:
- Patient refusal.
- Contraindication of breast conservative therapy:
- Pregnancy.
- Diffuse microcalcifications.
- Patient choice for mastectomy.
- Collagen / vascular disease.
- Multicentric tumor.
- Psychological co-morbidity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Oncology Center
Al Mansurah, DK, 35516, Egypt
Related Publications (3)
Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979 Feb;5(2):257-61. doi: 10.1016/0360-3016(79)90729-6. No abstract available.
PMID: 110740BACKGROUNDTobin GR. Pectoralis major segmental anatomy and segmentally split pectoralis major flaps. Plast Reconstr Surg. 1985 Jun;75(6):814-24. doi: 10.1097/00006534-198506000-00009.
PMID: 4001201BACKGROUNDFisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002 Oct 17;347(16):1233-41. doi: 10.1056/NEJMoa022152.
PMID: 12393820BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osama Hussein, MD,PhD.FEBS
Mansoura University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
September 13, 2019
First Posted
September 17, 2019
Study Start
August 24, 2019
Primary Completion
January 30, 2021
Study Completion
February 28, 2022
Last Updated
November 19, 2020
Record last verified: 2020-11